These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 12174319)

  • 1. When oral agents fail: practical barriers to starting insulin.
    Korytkowski M
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S18-24. PubMed ID: 12174319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin.
    Petrak F; Herpertz S; Stridde E; Pfützner A
    Diabetes Technol Ther; 2013 Aug; 15(8):703-11. PubMed ID: 23844571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges.
    Davies M
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S14-22. PubMed ID: 15306833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fear, guilt feelings and misconceptions: barriers to effective insulin treatment in type 2 diabetes.
    Benroubi M
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S97-9. PubMed ID: 21864760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town.
    Haque M; Emerson SH; Dennison CR; Navsa M; Levitt NS
    S Afr Med J; 2005 Oct; 95(10):798-802. PubMed ID: 16341336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to insulin initiation and intensification and how to overcome them.
    Kunt T; Snoek FJ
    Int J Clin Pract Suppl; 2009 Oct; (164):6-10. PubMed ID: 19751453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges associated with insulin therapy in type 2 diabetes mellitus.
    Edelman S; Pettus J
    Am J Med; 2014 Oct; 127(10 Suppl):S11-6. PubMed ID: 25282008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes.
    Ross SA; Tildesley HD; Ashkenas J
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():13-20. PubMed ID: 21942467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualizing care with injectable glucose-lowering agents.
    Miller EM
    J Fam Pract; 2013 Dec; 62(12 Suppl CME):S12-9. PubMed ID: 24340344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C
    Diabetes Educ; 2006; 32(6):910-7. PubMed ID: 17102158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of therapeutic advances on hypoglycaemia in type 2 diabetes.
    Boyle PJ; Zrebiec J
    Diabetes Metab Res Rev; 2008; 24(4):257-85. PubMed ID: 18232062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Before oral agents fail: the case for starting insulin early.
    Marre M
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S25-30. PubMed ID: 12174320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in insulin therapy for type 2 diabetes.
    Sorli C
    Am J Med; 2014 Oct; 127(10 Suppl):S39-48. PubMed ID: 25282012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of insulin for type 2 diabetes mellitus patients: what are the issues? A qualitative study.
    Tan AM; Muthusamy L; Ng CC; Phoon KY; Ow JH; Tan NC
    Singapore Med J; 2011 Nov; 52(11):801-9. PubMed ID: 22173249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine.
    Bradley C; Gilbride CJ
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():50-65. PubMed ID: 18577157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
    Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
    Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin initiation in type 2 diabetes: what are the treatment regimen options and how can we best help patients feel empowered?
    Spollett GR
    J Am Acad Nurse Pract; 2012 Apr; 24 Suppl 1():249-59. PubMed ID: 22564101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological insulin resistance in geriatric patients with diabetes mellitus.
    Bahrmann A; Abel A; Zeyfang A; Petrak F; Kubiak T; Hummel J; Oster P; Bahrmann P
    Patient Educ Couns; 2014 Mar; 94(3):417-22. PubMed ID: 24341962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early use of insulin in type 2 diabetes.
    Eldor R; Stern E; Milicevic Z; Raz I
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S30-5. PubMed ID: 15955372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.